Skip to main content
Glama

Yesterdays Number

by io.github.pipeworx-io

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond annotations (readOnlyHint, openWorldHint, idempotentHint), the description explains that company comparisons pull latest 10-K financials with correct fiscal year handling, while drug comparisons pull FAERS/FDA/trial counts. It also mentions sorted results and citation URIs, adding valuable behavioral context.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is a single well-organized paragraph that front-loads example queries, then concisely covers behavior for both entity types. Every sentence adds value without repetition or fluff.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite no output schema, the description thoroughly explains return format (paired data with citation URIs) and covers all essential aspects: entity types, data sources, sorting, and efficiency gains. It provides comprehensive guidance for an agent to use the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

With 100% schema coverage, baseline is 3. The description clarifies the 'type' parameter by distinguishing company vs drug data sources and provides concrete examples for the 'values' parameter (tickers/CIKs for companies, drug names for drugs), adding useful semantics beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool performs side-by-side comparisons of 2-5 companies or drugs in one parallel call. It provides natural language examples and explicitly contrasts with sequential single-pack lookups, distinguishing it from sibling tools.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly instructs to 'ALWAYS PREFER over sequential single-pack lookups when comparing entities,' giving clear when-to-use guidance. It also details the data retrieved per entity type, providing context for appropriate use.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Yesterdays Number toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation3/5

Many tools have overlapping purposes, such as multiple query tools (ask_pipeworx, ask_pipeworx_grounded, deep_research) and prediction market analysis tools (bet_research, polymarket_arbitrage, polymarket_edges). While descriptions help differentiate, the clustering of similar functions may cause confusion.

Naming Consistency4/5

All tools use snake_case, but the pattern varies: some start with verbs (forget, remember, recall) while others start with nouns (entity_profile, pipeworx_trending). The naming is generally clear with minor inconsistencies.

Tool Count4/5

With 31 tools, the set is slightly large but appropriate given the broad scope covering company data, prediction markets, memory, subscriptions, and more. A few tools like yesterdays_number_get seem out of place, but overall the count is reasonable.

Completeness3/5

The tool set covers many domains comprehensively (SEC, FDA, FRED, prediction markets), but there are notable gaps such as no direct web search or stock price tool beyond routed queries. The server feels like a collection of capabilities rather than a unified domain.

Resources